Carta al Director
Uso de la heparina no fraccionada para la inhibición del metabolismo glucídico miocárdico en los estudios PET/TC con 18F-FDG
Use of unfractionated heparin for the suppression of myocardial glucose metabolism in 18F-FDG PET/CT studies
J.P. Suárez Fernández
, F.M. González García
Autor para correspondencia
Servicio de Medicina Nuclear, Hospital Universitario Central de Asturias, Oviedo, España
Leído
227
Vecesse ha leído el artículo
67
Total PDF
160
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 1 | 0 | 1 |
| 2025 2 | 11 | 0 | 11 |
| 2024 11 | 3 | 2 | 5 |
| 2024 10 | 2 | 0 | 2 |
| 2024 2 | 1 | 2 | 3 |
| 2023 12 | 1 | 2 | 3 |
| 2023 11 | 1 | 2 | 3 |
| 2023 10 | 1 | 0 | 1 |
| 2023 6 | 2 | 2 | 4 |
| 2023 4 | 0 | 1 | 1 |
| 2023 3 | 1 | 1 | 2 |
| 2023 2 | 26 | 4 | 30 |
| 2022 10 | 1 | 2 | 3 |
| 2022 9 | 1 | 0 | 1 |
| 2022 6 | 1 | 0 | 1 |
| 2022 5 | 1 | 2 | 3 |
| 2022 3 | 3 | 0 | 3 |
| 2021 1 | 3 | 4 | 7 |
| 2021 12 | 1 | 0 | 1 |
| 2021 11 | 1 | 0 | 1 |
| 2021 10 | 2 | 2 | 4 |
| 2021 9 | 2 | 2 | 4 |
| 2021 8 | 1 | 0 | 1 |
| 2021 7 | 2 | 0 | 2 |
| 2021 6 | 3 | 4 | 7 |
| 2021 5 | 5 | 2 | 7 |
| 2021 4 | 31 | 0 | 31 |
| 2021 3 | 8 | 14 | 22 |
| 2021 2 | 31 | 8 | 39 |
| 2020 1 | 13 | 7 | 20 |
| 2020 10 | 0 | 2 | 2 |
| 2020 9 | 0 | 2 | 2 |
Mostrar todo
